Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Sydney Melanoma Diagnostic Centre (SMDC) is a world-renowned clinical and research facility based at the Royal Prince Alfred Hospital in Sydney, Australia. Specializing in the early detection and management of melanoma and other skin cancers, the centre utilizes state-of-the-art diagnostic technologies such as 3D total body photography and in vivo reflectance confocal microscopy. SMDC operates as a critical clinical arm of the Sydney Local Health District and maintains a deep integration with the Melanoma Institute Australia and the University of Sydney. The centre is a major hub for dermatological research and international clinical trials, providing multidisciplinary care for high-risk patients. Its work focuses on improving survival rates through precision diagnostics and the development of non-invasive monitoring protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sydney Melanoma Diagnostic Centre.